IONS Ionis Pharmaceuticals | $28.52
-0.7% | 4/3/2025 | Reiterated by | Guggenheim | Analyst Debjit Chattopadhyay | Buy -> Buy | | High | View details for Guggenheim rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 4/3/2025 |
ARQT Arcutis Biotherapeutics | $16.16
-2.7% | 4/3/2025 | Reiterated by | Guggenheim | Analyst Seamus Fernandez | Buy -> Buy | | Medium | View details for Guggenheim rating of Arcutis Biotherapeutics (NASDAQ:ARQT) on 4/3/2025 |
RH RH | $149.95
-39.9% | 4/3/2025 | Target Lowered by | Guggenheim | Analyst Steven Forbes | Buy -> Buy | $500.00 -> $300.00 | High | View details for Guggenheim rating of RH (NYSE:RH) on 4/3/2025 |
KR Kroger | $70.59
+4.9% | 4/3/2025 | Target Raised by | Guggenheim | Analyst John Heinbockel | Buy -> Buy | $71.00 -> $73.00 | High | View details for Guggenheim rating of Kroger (NYSE:KR) on 4/3/2025 |
NFLX Netflix | $917.05
-2.0% | 4/3/2025 | Reiterated by | Guggenheim | Analyst Michael Morris | Buy -> Buy | $1,100.00 -> $1,100.00 | Low | View details for Guggenheim rating of Netflix (NASDAQ:NFLX) on 4/3/2025 |
SRAD Sportradar Group | $21.19
-4.5% | 4/3/2025 | Reiterated by | Guggenheim | Analyst C. Baker | Buy -> Buy | $27.00 -> $27.00 | Low | View details for Guggenheim rating of Sportradar Group (NASDAQ:SRAD) on 4/3/2025 |
ORCL Oracle | $137.04
-6.0% | 4/3/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Buy -> Buy | $220.00 -> $220.00 | Low | View details for Guggenheim rating of Oracle (NYSE:ORCL) on 4/3/2025 |
TWST Twist Bioscience | $37.50
-1.9% | 3/28/2025 | Target Set by | Guggenheim | - | | $50.00 | High | View details for Guggenheim rating of Twist Bioscience (NASDAQ:TWST) on 3/28/2025 |
CMPX Compass Therapeutics | $1.61
-5.0% | 4/2/2025 | Reiterated by | Guggenheim | Analyst M. Schmidt | Buy -> Buy | $12.00 -> $12.00 | High | View details for Guggenheim rating of Compass Therapeutics (NASDAQ:CMPX) on 4/2/2025 |
MAZE Maze Therapeutics | $9.32
-10.1% | 4/2/2025 | Reiterated by | Guggenheim | Analyst D. Chattopadhyay | Buy -> Buy | $19.00 -> $19.00 | Medium | View details for Guggenheim rating of Maze Therapeutics (NASDAQ:MAZE) on 4/2/2025 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. |
SNAP Snap | $8.06
-9.3% | 4/2/2025 | Reiterated by | Guggenheim | Analyst M. Morris | Neutral -> Neutral | | Low | View details for Guggenheim rating of Snap (NYSE:SNAP) on 4/2/2025 |
PHAT Phathom Pharmaceuticals | $5.01
-8.7% | 4/2/2025 | Reiterated by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | | High | View details for Guggenheim rating of Phathom Pharmaceuticals (NASDAQ:PHAT) on 4/2/2025 |
JNJ Johnson & Johnson | $159.90
+2.9% | 4/2/2025 | Reiterated by | Guggenheim | Analyst Vamil Divan | Neutral -> Neutral | | Low | View details for Guggenheim rating of Johnson & Johnson (NYSE:JNJ) on 4/2/2025 |
PINS Pinterest | $27.54
-12.2% | 4/1/2025 | Reiterated by | Guggenheim | Analyst M. Morris | Buy -> Buy | | Low | View details for Guggenheim rating of Pinterest (NYSE:PINS) on 4/1/2025 |
SR Spire | $79.07
+0.3% | 4/1/2025 | Target Raised by | Guggenheim | Analyst Shahriar Pourreza | Neutral -> Neutral | $67.00 -> $72.00 | Medium | View details for Guggenheim rating of Spire (NYSE:SR) on 4/1/2025 |
PRGS Progress Software | $57.99
-1.7% | 4/1/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Buy -> Buy | $83.00 -> $83.00 | High | View details for Guggenheim rating of Progress Software (NASDAQ:PRGS) on 4/1/2025 |
PMN ProMIS Neurosciences | $0.64
-10.0% | 4/1/2025 | Reiterated by | Guggenheim | Analyst Eddie Hickman | Buy -> Buy | $6.00 -> $6.00 | High | View details for Guggenheim rating of ProMIS Neurosciences (NASDAQ:PMN) on 4/1/2025 |
CABA Cabaletta Bio | $1.19
-4.0% | 4/1/2025 | Reiterated by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | $23.00 -> $23.00 | High | View details for Guggenheim rating of Cabaletta Bio (NASDAQ:CABA) on 4/1/2025 |
ADCT ADC Therapeutics | $1.24
-7.1% | 3/31/2025 | Target Lowered by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | $10.00 -> $7.00 | High | View details for Guggenheim rating of ADC Therapeutics (NYSE:ADCT) on 3/31/2025 |
BROS Dutch Bros | $57.00
-9.0% | 3/31/2025 | Target Raised by | Guggenheim | Analyst Gregory Francfort | Buy -> Buy | $54.00 -> $72.00 | Medium | View details for Guggenheim rating of Dutch Bros (NYSE:BROS) on 3/31/2025 |
DLTR Dollar Tree | $67.22
-13.3% | 3/28/2025 | Target Lowered by | Guggenheim | Analyst John Heinbockel | Buy -> Buy | $100.00 -> $95.00 | Medium | View details for Guggenheim rating of Dollar Tree (NASDAQ:DLTR) on 3/28/2025 |
MRUS Merus | $41.73
-3.0% | 3/28/2025 | Reiterated by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | $109.00 -> $109.00 | Low | View details for Guggenheim rating of Merus (NASDAQ:MRUS) on 3/28/2025 |
IPSC Century Therapeutics | $0.46
-2.3% | 3/28/2025 | Reiterated by | Guggenheim | Analyst Kelsey Goodwin | Buy -> Buy | | High | View details for Guggenheim rating of Century Therapeutics (NASDAQ:IPSC) on 3/28/2025 |
SLNO Soleno Therapeutics | $72.16
-2.0% | 3/28/2025 | Reiterated by | Guggenheim | Analyst Debjit Chattopadhyay | Buy -> Buy | $70.00 -> $81.00 | High | View details for Guggenheim rating of Soleno Therapeutics (NASDAQ:SLNO) on 3/28/2025 |
CSTL Castle Biosciences | $19.19
-5.0% | 3/28/2025 | Target Set by | Guggenheim | Analyst Subbu Nambi | Buy -> Buy | $30.00 | High | View details for Guggenheim rating of Castle Biosciences (NASDAQ:CSTL) on 3/28/2025 |
EXAS Exact Sciences | $44.28
-0.6% | 3/28/2025 | Target Set by | Guggenheim | Analyst Subbu Nambi | Buy -> Buy | $60.00 | High | View details for Guggenheim rating of Exact Sciences (NASDAQ:EXAS) on 3/28/2025 |
CNTA Centessa Pharmaceuticals | $13.06
-4.7% | 3/26/2025 | Reiterated by | Guggenheim | Analyst Debjit Chattopadhyay | Buy -> Buy | $28.00 -> $28.00 | High | View details for Guggenheim rating of Centessa Pharmaceuticals (NASDAQ:CNTA) on 3/26/2025 |
RH RH | $149.95
-39.9% | 3/26/2025 | Target Lowered by | Guggenheim | Analyst Steven Forbes | Buy -> Buy | $550.00 -> $500.00 | Medium | View details for Guggenheim rating of RH (NYSE:RH) on 3/26/2025 |
IFRX InflaRx | $1.05
-8.7% | 3/26/2025 | Target Raised by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | $7.00 -> $10.00 | High | View details for Guggenheim rating of InflaRx (NASDAQ:IFRX) on 3/26/2025 |
ADAP Adaptimmune Therapeutics | $0.32
+6.2% | 3/26/2025 | Target Lowered by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | $3.00 -> $1.75 | High | View details for Guggenheim rating of Adaptimmune Therapeutics (NASDAQ:ADAP) on 3/26/2025 |
ZURA Zura Bio | $1.09
-7.3% | 3/26/2025 | Reiterated by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | $15.00 -> $15.00 | Medium | View details for Guggenheim rating of Zura Bio (NASDAQ:ZURA) on 3/26/2025 |
MTZ MasTec | $111.95
-8.8% | 3/25/2025 | Reiterated by | Guggenheim | Analyst J. Osha | Buy -> Buy | $195.00 -> $195.00 | Low | View details for Guggenheim rating of MasTec (NYSE:MTZ) on 3/25/2025 |
FOXA FOX | $51.83
-9.1% | 3/25/2025 | Reiterated by | Guggenheim | Analyst Michael Morris | Buy -> Buy | $60.00 -> $60.00 | Medium | View details for Guggenheim rating of FOX (NASDAQ:FOXA) on 3/25/2025 |
LRMR Larimar Therapeutics | $1.98
-10.0% | 3/25/2025 | Reiterated by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | $26.00 -> $26.00 | Medium | View details for Guggenheim rating of Larimar Therapeutics (NASDAQ:LRMR) on 3/25/2025 |
VERV Verve Therapeutics | $3.85
-1.5% | 3/25/2025 | Reiterated by | Guggenheim | Analyst Seamus Fernandez | Buy -> Buy | | High | View details for Guggenheim rating of Verve Therapeutics (NASDAQ:VERV) on 3/25/2025 |
ASMB Assembly Biosciences | $9.31
-1.7% | 3/25/2025 | Initiated by | Guggenheim | Analyst Vamil Divan | Buy | $31.00 | Low | View details for Guggenheim rating of Assembly Biosciences (NASDAQ:ASMB) on 3/25/2025 |
DRI Darden Restaurants | $200.60
-4.3% | 3/24/2025 | Target Raised by | Guggenheim | Analyst Greg Francfort | Buy -> Buy | $205.00 -> $220.00 | High | View details for Guggenheim rating of Darden Restaurants (NYSE:DRI) on 3/24/2025 |
VSTM Verastem | $5.70
-2.4% | 3/24/2025 | Target Raised by | Guggenheim | Analyst M. Schmidt | Buy -> Buy | $13.00 -> $14.00 | Medium | View details for Guggenheim rating of Verastem (NASDAQ:VSTM) on 3/24/2025 |
VALN Valneva | $6.97
+0.7% | 3/24/2025 | Target Lowered by | Guggenheim | Analyst Dana Flanders | Buy -> Buy | $17.00 -> $15.00 | High | View details for Guggenheim rating of Valneva (NASDAQ:VALN) on 3/24/2025 |
PINS Pinterest | $27.54
-12.2% | 3/24/2025 | Upgraded by | Guggenheim | Analyst Michael Morris | Neutral -> Buy | $39.00 -> $40.00 | Low | View details for Guggenheim rating of Pinterest (NYSE:PINS) on 3/24/2025 |
Trump Orders 'National Digital Asset Stockpile' (Ad) ‘Digital Asset Reserve’ for THIS Coin???
Get all the details before this story gains even more traction SHOW ME THE #1 CRYPTO TO OWN RIGHT NOW |
ACN Accenture | $301.34
-4.7% | 3/21/2025 | Target Lowered by | Guggenheim | Analyst Jonathan Lee | Buy -> Buy | $400.00 -> $395.00 | High | View details for Guggenheim rating of Accenture (NYSE:ACN) on 3/21/2025 |
DTE DTE Energy | $139.36
+1.0% | 3/21/2025 | Target Raised by | Guggenheim | Analyst S. Pourreza | Buy -> Buy | $139.00 -> $147.00 | Medium | View details for Guggenheim rating of DTE Energy (NYSE:DTE) on 3/21/2025 |
IPSC Century Therapeutics | $0.46
-2.3% | 3/21/2025 | Target Lowered by | Guggenheim | Analyst Kelsey Goodwin | Buy -> Buy | $12.00 -> $5.00 | Medium | View details for Guggenheim rating of Century Therapeutics (NASDAQ:IPSC) on 3/21/2025 |
FIVE Five Below | $58.83
-27.8% | 3/21/2025 | Target Lowered by | Guggenheim | Analyst John Heinbockel | Buy -> Buy | $140.00 -> $125.00 | Medium | View details for Guggenheim rating of Five Below (NASDAQ:FIVE) on 3/21/2025 |
ACET Adicet Bio | $0.67
-7.3% | 3/21/2025 | Reiterated by | Guggenheim | Analyst M. Schmidt | Buy -> Buy | $7.00 -> $7.00 | Low | View details for Guggenheim rating of Adicet Bio (NASDAQ:ACET) on 3/21/2025 |
NEE NextEra Energy | $72.08
+2.3% | 3/20/2025 | Reiterated by | Guggenheim | Analyst Shahriar Pourreza | Buy -> Buy | $89.00 -> $89.00 | Low | View details for Guggenheim rating of NextEra Energy (NYSE:NEE) on 3/20/2025 |
IMVT Immunovant | $15.78
-3.9% | 3/20/2025 | Reiterated by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | | High | View details for Guggenheim rating of Immunovant (NASDAQ:IMVT) on 3/20/2025 |
RDDT Reddit | $96.78
-11.6% | 3/20/2025 | Target Lowered by | Guggenheim | Analyst M. Morris | Buy -> Buy | $210.00 -> $170.00 | Medium | View details for Guggenheim rating of Reddit (NYSE:RDDT) on 3/20/2025 |
IMNM Immunome | $6.24
-7.0% | 3/20/2025 | Target Lowered by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | $35.00 -> $25.00 | Medium | View details for Guggenheim rating of Immunome (NASDAQ:IMNM) on 3/20/2025 |
ABSI Absci | $2.23
-10.1% | 3/20/2025 | Reiterated by | Guggenheim | Analyst V. Divan | Buy -> Buy | $10.00 -> $10.00 | Medium | View details for Guggenheim rating of Absci (NASDAQ:ABSI) on 3/20/2025 |
EOSE Eos Energy Enterprises | $3.97
-0.5% | 3/18/2025 | Reiterated by | Guggenheim | Analyst Joseph Osha | Buy -> Buy | $7.00 -> $7.00 | Low | View details for Guggenheim rating of Eos Energy Enterprises (NASDAQ:EOSE) on 3/18/2025 |
MRUS Merus | $41.73
-3.0% | 3/18/2025 | Reiterated by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | $109.00 -> $109.00 | Low | View details for Guggenheim rating of Merus (NASDAQ:MRUS) on 3/18/2025 |
PFE Pfizer | $24.30
-1.6% | 3/18/2025 | Reiterated by | Guggenheim | Analyst Vamil Divan | Buy -> Buy | | Low | View details for Guggenheim rating of Pfizer (NYSE:PFE) on 3/18/2025 |
ZBIO Zenas Biopharma | $7.80
-7.5% | 3/12/2025 | Reiterated by | Guggenheim | Analyst Y. Suneja | Buy -> Buy | $45.00 -> $45.00 | Medium | View details for Guggenheim rating of Zenas Biopharma (NASDAQ:ZBIO) on 3/12/2025 |
RBRK Rubrik | $57.40
-8.1% | 3/18/2025 | Target Raised by | Guggenheim | Analyst John Difucci | Buy -> Buy | $76.00 -> $80.00 | Low | View details for Guggenheim rating of Rubrik (NYSE:RBRK) on 3/18/2025 |
GENI Genius Sports | $9.51
-7.2% | 3/18/2025 | Initiated by | Guggenheim | Analyst Curry Baker | Buy | $12.00 | High | View details for Guggenheim rating of Genius Sports (NYSE:GENI) on 3/18/2025 |
INCY Incyte | $62.46
+0.2% | 3/18/2025 | Downgraded by | Guggenheim | Analyst Michael Schmidt | Buy -> Neutral | $92.00 -> $92.00 | High | View details for Guggenheim rating of Incyte (NASDAQ:INCY) on 3/18/2025 |
GNRC Generac | $115.78
-9.7% | 3/17/2025 | Upgraded by | Guggenheim | Analyst J. Osha | Sell -> Neutral | | Low | View details for Guggenheim rating of Generac (NYSE:GNRC) on 3/17/2025 |
ZVRA Zevra Therapeutics | $7.43
-3.0% | 3/13/2025 | Target Raised by | Guggenheim | Analyst E. Hickman | Buy -> Buy | $20.00 -> $22.00 | Medium | View details for Guggenheim rating of Zevra Therapeutics (NASDAQ:ZVRA) on 3/13/2025 |
ARVN Arvinas | $6.90
-3.9% | 3/13/2025 | Target Lowered by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | $57.00 -> $32.00 | Low | View details for Guggenheim rating of Arvinas (NASDAQ:ARVN) on 3/13/2025 |
GHRS GH Research | $9.86
-5.2% | 3/13/2025 | Initiated by | Guggenheim | Analyst Eddie Hickman | Buy | $32.00 | Medium | View details for Guggenheim rating of GH Research (NASDAQ:GHRS) on 3/13/2025 |
CYBN Cybin | $5.96
-4.8% | 3/13/2025 | Initiated by | Guggenheim | Analyst Eddie Hickman | Buy | $35.00 | High | View details for Guggenheim rating of Cybin (NYSE:CYBN) on 3/13/2025 |
LEGN Legend Biotech | $32.88
-1.1% | 3/12/2025 | Reiterated by | Guggenheim | Analyst Michael Schmidt | Neutral -> Neutral | | Medium | View details for Guggenheim rating of Legend Biotech (NASDAQ:LEGN) on 3/12/2025 |
DKS DICK'S Sporting Goods | $184.89
-12.5% | 3/12/2025 | Reiterated by | Guggenheim | Analyst Steven Forbes | Neutral -> Neutral | | Low | View details for Guggenheim rating of DICK’S Sporting Goods (NYSE:DKS) on 3/12/2025 |
DNTH Dianthus Therapeutics | $16.97
-5.0% | 3/12/2025 | Reiterated by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | $84.00 -> $84.00 | High | View details for Guggenheim rating of Dianthus Therapeutics (NASDAQ:DNTH) on 3/12/2025 |
PCVX Vaxcyte | $30.56
-9.3% | 3/12/2025 | Reiterated by | Guggenheim | Analyst Seamus Fernandez | Buy -> Buy | $160.00 -> $160.00 | Low | View details for Guggenheim rating of Vaxcyte (NASDAQ:PCVX) on 3/12/2025 |
PFE Pfizer | $24.30
-1.6% | 3/12/2025 | Reiterated by | Guggenheim | Analyst Vamil Divan | Buy -> Buy | | Low | View details for Guggenheim rating of Pfizer (NYSE:PFE) on 3/12/2025 |
TSLA Tesla | $267.28
-5.5% | 3/12/2025 | Target Lowered by | Guggenheim | Analyst Ronald Jewsikow | Sell -> Sell | $175.00 -> $170.00 | Low | View details for Guggenheim rating of Tesla (NASDAQ:TSLA) on 3/12/2025 |
GNTX Gentex | $22.36
-4.9% | 3/5/2025 | Target Set by | Guggenheim | - | | $30.00 | Low | View details for Guggenheim rating of Gentex (NASDAQ:GNTX) on 3/5/2025 |
ANAB AnaptysBio | $19.29
+1.7% | 3/3/2025 | Reiterated by | Guggenheim | - | Buy -> Buy | | High | View details for Guggenheim rating of AnaptysBio (NASDAQ:ANAB) on 3/3/2025 |
GTN Gray Television | $3.92
-10.2% | 3/10/2025 | Target Lowered by | Guggenheim | Analyst Curry Baker | Buy -> Buy | $8.00 -> $7.00 | Medium | View details for Guggenheim rating of Gray Television (NYSE:GTN) on 3/10/2025 |
ORLY O'Reilly Automotive | $1,441.89
+1.8% | 3/10/2025 | Reiterated by | Guggenheim | Analyst Steven Forbes | Buy -> Buy | $1,475.00 -> $1,475.00 | Low | View details for Guggenheim rating of O’Reilly Automotive (NASDAQ:ORLY) on 3/10/2025 |
W Wayfair | $25.05
-25.7% | 3/10/2025 | Reiterated by | Guggenheim | Analyst Steven Forbes | Buy -> Buy | $60.00 -> $60.00 | Low | View details for Guggenheim rating of Wayfair (NYSE:W) on 3/10/2025 |
JNJ Johnson & Johnson | $159.90
+2.9% | 3/10/2025 | Reiterated by | Guggenheim | Analyst Vamil Divan | Neutral -> Neutral | | Medium | View details for Guggenheim rating of Johnson & Johnson (NYSE:JNJ) on 3/10/2025 |
IMVT Immunovant | $15.78
-3.9% | 3/10/2025 | Reiterated by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | | Low | View details for Guggenheim rating of Immunovant (NASDAQ:IMVT) on 3/10/2025 |
NAUT Nautilus Biotechnology | $0.75
-15.8% | 2/28/2025 | Target Set by | Guggenheim | - | | $2.50 | High | View details for Guggenheim rating of Nautilus Biotechnology (NASDAQ:NAUT) on 2/28/2025 |
ONC Beigene | $264.32
-3.8% | 2/28/2025 | Reiterated by | Guggenheim | - | Buy -> Buy | | Low | View details for Guggenheim rating of Beigene (NASDAQ:ONC) on 2/28/2025 |
FWONA Formula One Group | $78.03
-4.7% | 3/3/2025 | Reiterated by | Guggenheim | - | Buy -> Buy | | Low | View details for Guggenheim rating of Formula One Group (NASDAQ:FWONA) on 3/3/2025 |
ARGX argenx | $590.06
+1.1% | 3/10/2025 | Target Raised by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | $775.00 -> $1,100.00 | Medium | View details for Guggenheim rating of argenx (NASDAQ:ARGX) on 3/10/2025 |
IHRT iHeartMedia | $1.33
-13.1% | 3/10/2025 | Target Lowered by | Guggenheim | Analyst Curry Baker | Buy -> Buy | $5.00 -> $4.50 | Medium | View details for Guggenheim rating of iHeartMedia (NASDAQ:IHRT) on 3/10/2025 |
SBGI Sinclair | $14.74
-8.4% | 3/10/2025 | Target Lowered by | Guggenheim | Analyst Curry Baker | Buy -> Buy | $19.00 -> $17.00 | High | View details for Guggenheim rating of Sinclair (NASDAQ:SBGI) on 3/10/2025 |
VG Venture Global | $8.94
-10.2% | 3/10/2025 | Target Lowered by | Guggenheim | Analyst S. Pourreza | Buy -> Buy | $27.00 -> $20.00 | High | View details for Guggenheim rating of Venture Global (NYSE:VG) on 3/10/2025 |
BWA BorgWarner | $27.22
-6.5% | 3/5/2025 | Target Set by | Guggenheim | - | | $38.00 | N/A | View details for Guggenheim rating of BorgWarner (NYSE:BWA) on 3/5/2025 |
PHAT Phathom Pharmaceuticals | $5.01
-8.7% | 3/7/2025 | Target Set by | Guggenheim | - | | $18.00 | N/A | View details for Guggenheim rating of Phathom Pharmaceuticals (NASDAQ:PHAT) on 3/7/2025 |
AVBP ArriVent BioPharma | $16.94
-5.9% | 3/10/2025 | Initiated by | Guggenheim | Analyst Michael Schmidt | Buy | $45.00 | Medium | View details for Guggenheim rating of ArriVent BioPharma (NASDAQ:AVBP) on 3/10/2025 |
NMRA Neumora Therapeutics | $0.85
-9.7% | 3/7/2025 | Downgraded by | Guggenheim | Analyst Yatin Suneja | Buy -> Neutral | | High | View details for Guggenheim rating of Neumora Therapeutics (NASDAQ:NMRA) on 3/7/2025 |
ARRY Array Technologies | $4.43
-10.3% | 3/7/2025 | Upgraded by | Guggenheim | Analyst J. Osha | Neutral -> Buy | $10.00 | N/A | View details for Guggenheim rating of Array Technologies (NASDAQ:ARRY) on 3/7/2025 |
NOVA Sunnova Energy International | $0.33
-5.9% | 3/5/2025 | Upgraded by | Guggenheim | Analyst J. Osha | Hold -> Strong-Buy | | Medium | View details for Guggenheim rating of Sunnova Energy International (NYSE:NOVA) on 3/5/2025 |
ANIP ANI Pharmaceuticals | $68.29
-1.5% | 3/5/2025 | Target Raised by | Guggenheim | Analyst Vamil Divan | Buy -> Buy | $84.00 -> $86.00 | Medium | View details for Guggenheim rating of ANI Pharmaceuticals (NASDAQ:ANIP) on 3/5/2025 |
AZO AutoZone | $3,825.79
+0.4% | 3/5/2025 | Target Raised by | Guggenheim | Analyst Steven Forbes | Buy -> Buy | $3,750.00 -> $3,850.00 | Medium | View details for Guggenheim rating of AutoZone (NYSE:AZO) on 3/5/2025 |
Trump Orders 'National Digital Asset Stockpile' (Ad) ‘Digital Asset Reserve’ for THIS Coin???
Get all the details before this story gains even more traction SHOW ME THE #1 CRYPTO TO OWN RIGHT NOW |
DUK Duke Energy | $124.00
+3.0% | 3/5/2025 | Target Raised by | Guggenheim | Analyst Shahriar Pourreza | Buy -> Buy | $132.00 -> $135.00 | Low | View details for Guggenheim rating of Duke Energy (NYSE:DUK) on 3/5/2025 |
FUN Cedar Fair | $31.99
-14.4% | 3/5/2025 | Target Lowered by | Guggenheim | Analyst C. Baker | Buy -> Buy | $55.00 -> $50.00 | Low | View details for Guggenheim rating of Cedar Fair (NYSE:FUN) on 3/5/2025 |
ORCL Oracle | $137.04
-6.0% | 3/5/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Buy -> Buy | $220.00 -> $220.00 | Medium | View details for Guggenheim rating of Oracle (NYSE:ORCL) on 3/5/2025 |
CRWD CrowdStrike | $347.39
-6.5% | 3/5/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Neutral -> Neutral | | High | View details for Guggenheim rating of CrowdStrike (NASDAQ:CRWD) on 3/5/2025 |
BBY Best Buy | $62.22
-17.8% | 3/5/2025 | Target Lowered by | Guggenheim | Analyst Steven Forbes | Buy -> Buy | $105.00 -> $90.00 | Medium | View details for Guggenheim rating of Best Buy (NYSE:BBY) on 3/5/2025 |
GEV GE Vernova | $297.33
-10.1% | 3/5/2025 | Upgraded by | Guggenheim | Analyst J. Osha | Neutral -> Buy | $380.00 | Medium | View details for Guggenheim rating of GE Vernova (NYSE:GEV) on 3/5/2025 |
SION Sionna Therapeutics | $11.61
-1.9% | 3/4/2025 | Initiated by | Guggenheim | Analyst Y. Suneja | Buy | $45.00 | Low | View details for Guggenheim rating of Sionna Therapeutics (NASDAQ:SION) on 3/4/2025 |
FE FirstEnergy | $40.99
+1.0% | 2/28/2025 | Target Lowered by | Guggenheim | Analyst Shahriar Pourreza | Buy -> Buy | $52.00 -> $45.00 | Medium | View details for Guggenheim rating of FirstEnergy (NYSE:FE) on 2/28/2025 |
ESTC Elastic | $82.33
-9.9% | 2/28/2025 | Target Raised by | Guggenheim | Analyst H. Ma | Buy -> Buy | $130.00 -> $136.00 | High | View details for Guggenheim rating of Elastic (NYSE:ESTC) on 2/28/2025 |
NXST Nexstar Media Group | $166.96
-8.2% | 2/28/2025 | Target Raised by | Guggenheim | Analyst Curry Baker | Buy -> Buy | $210.00 -> $220.00 | Low | View details for Guggenheim rating of Nexstar Media Group (NASDAQ:NXST) on 2/28/2025 |
LTH Life Time Group | $29.33
-6.3% | 2/28/2025 | Target Raised by | Guggenheim | Analyst John Heinbockel | Buy -> Buy | $32.00 -> $36.00 | High | View details for Guggenheim rating of Life Time Group (NYSE:LTH) on 2/28/2025 |
CRM Salesforce | $255.06
-6.1% | 2/27/2025 | Reiterated by | Guggenheim | Analyst J. Difucci | Sell -> Sell | $247.00 -> $247.00 | High | View details for Guggenheim rating of Salesforce (NYSE:CRM) on 2/27/2025 |
PARA Paramount Global | $11.48
-3.5% | 2/27/2025 | Reiterated by | Guggenheim | Analyst Michael Morris | Buy -> Buy | $14.00 -> $14.00 | Low | View details for Guggenheim rating of Paramount Global (NASDAQ:PARA) on 2/27/2025 |
SNOW Snowflake | $139.63
-9.3% | 2/27/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Neutral -> Neutral | | High | View details for Guggenheim rating of Snowflake (NYSE:SNOW) on 2/27/2025 |
JACK Jack in the Box | $25.73
-3.0% | 2/27/2025 | Reiterated by | Guggenheim | Analyst Gregory Francfort | Buy -> Buy | $55.00 -> $55.00 | Medium | View details for Guggenheim rating of Jack in the Box (NASDAQ:JACK) on 2/27/2025 |
BEAM Beam Therapeutics | $16.46
-10.9% | 2/27/2025 | Reiterated by | Guggenheim | Analyst Debjit Chattopadhyay | Buy -> Buy | $78.00 -> $78.00 | High | View details for Guggenheim rating of Beam Therapeutics (NASDAQ:BEAM) on 2/27/2025 |
PLNT Planet Fitness | $97.46
-1.3% | 2/27/2025 | Reiterated by | Guggenheim | Analyst John Heinbockel | Buy -> Buy | $105.00 -> $105.00 | Low | View details for Guggenheim rating of Planet Fitness (NYSE:PLNT) on 2/27/2025 |
FSLR First Solar | $136.23
+4.9% | 2/27/2025 | Target Lowered by | Guggenheim | Analyst Joseph Osha | Buy -> Buy | $335.00 -> $304.00 | High | View details for Guggenheim rating of First Solar (NASDAQ:FSLR) on 2/27/2025 |
ITRI Itron | $100.84
-6.1% | 2/27/2025 | Target Lowered by | Guggenheim | Analyst Joseph Osha | Buy -> Buy | $135.00 -> $133.00 | Low | View details for Guggenheim rating of Itron (NASDAQ:ITRI) on 2/27/2025 |
TKO TKO Group | $150.50
-5.1% | 2/27/2025 | Target Raised by | Guggenheim | Analyst Curry Baker | Buy -> Buy | $170.00 -> $175.00 | High | View details for Guggenheim rating of TKO Group (NYSE:TKO) on 2/27/2025 |
TXRH Texas Roadhouse | $167.05
-3.0% | 2/27/2025 | Target Lowered by | Guggenheim | Analyst Gregory Francfort | Buy -> Buy | $205.00 -> $200.00 | Low | View details for Guggenheim rating of Texas Roadhouse (NASDAQ:TXRH) on 2/27/2025 |
VERA Vera Therapeutics | $22.74
-3.6% | 2/27/2025 | Target Raised by | Guggenheim | Analyst Vamil Divan | Buy -> Buy | $59.00 -> $61.00 | Low | View details for Guggenheim rating of Vera Therapeutics (NASDAQ:VERA) on 2/27/2025 |
NRG NRG Energy | $92.78
-9.8% | 2/27/2025 | Target Raised by | Guggenheim | Analyst Shahriar Pourreza | Buy -> Buy | $134.00 -> $145.00 | High | View details for Guggenheim rating of NRG Energy (NYSE:NRG) on 2/27/2025 |
PRKS United Parks & Resorts | $42.80
-10.8% | 2/27/2025 | Target Raised by | Guggenheim | Analyst Curry Baker | Buy -> Buy | $70.00 -> $72.00 | High | View details for Guggenheim rating of United Parks & Resorts (NYSE:PRKS) on 2/27/2025 |
BASE Couchbase | $15.96
-3.1% | 2/26/2025 | Target Lowered by | Guggenheim | Analyst Howard Ma | Buy -> Buy | $30.00 -> $26.00 | High | View details for Guggenheim rating of Couchbase (NASDAQ:BASE) on 2/26/2025 |
SRE Sempra | $70.77
-2.8% | 2/26/2025 | Target Lowered by | Guggenheim | Analyst Shahriar Pourreza | Buy -> Buy | $95.00 -> $87.00 | Low | View details for Guggenheim rating of Sempra (NYSE:SRE) on 2/26/2025 |
HD Home Depot | $355.77
-4.1% | 2/26/2025 | Reiterated by | Guggenheim | Analyst Steven Forbes | Buy -> Buy | $450.00 -> $450.00 | Medium | View details for Guggenheim rating of Home Depot (NYSE:HD) on 2/26/2025 |
WDAY Workday | $228.33
-3.0% | 2/26/2025 | Reiterated by | Guggenheim | Analyst J. Difucci | Neutral -> Neutral | | Medium | View details for Guggenheim rating of Workday (NASDAQ:WDAY) on 2/26/2025 |
PCVX Vaxcyte | $30.56
-9.3% | 2/26/2025 | Reiterated by | Guggenheim | Analyst Seamus Fernandez | Buy -> Buy | $160.00 -> $160.00 | High | View details for Guggenheim rating of Vaxcyte (NASDAQ:PCVX) on 2/26/2025 |
PEG Public Service Enterprise Group | $81.45
-2.8% | 2/26/2025 | Reiterated by | Guggenheim | Analyst Shahriar Pourreza | Buy -> Buy | $98.00 -> $98.00 | Medium | View details for Guggenheim rating of Public Service Enterprise Group (NYSE:PEG) on 2/26/2025 |
RBRK Rubrik | $57.40
-8.1% | 2/26/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Buy -> Buy | $76.00 -> $76.00 | Low | View details for Guggenheim rating of Rubrik (NYSE:RBRK) on 2/26/2025 |
ORIC ORIC Pharmaceuticals | $5.26
-9.0% | 2/26/2025 | Reiterated by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | | High | View details for Guggenheim rating of ORIC Pharmaceuticals (NASDAQ:ORIC) on 2/26/2025 |
PNW Pinnacle West Capital | $95.06
-0.4% | 2/26/2025 | Reiterated by | Guggenheim | Analyst Shahriar Pourreza | Buy -> Buy | $100.00 -> $100.00 | Medium | View details for Guggenheim rating of Pinnacle West Capital (NYSE:PNW) on 2/26/2025 |
PMN ProMIS Neurosciences | $0.64
-10.0% | 2/26/2025 | Reiterated by | Guggenheim | Analyst Eddie Hickman | Buy -> Buy | | High | View details for Guggenheim rating of ProMIS Neurosciences (NASDAQ:PMN) on 2/26/2025 |
SRAD Sportradar Group | $21.19
-4.5% | 2/26/2025 | Initiated by | Guggenheim | Analyst Curry Baker | Buy | $27.00 | Low | View details for Guggenheim rating of Sportradar Group (NASDAQ:SRAD) on 2/26/2025 |
MAZE Maze Therapeutics | $9.32
-10.1% | 2/25/2025 | Initiated by | Guggenheim | Analyst Debjit Chattopadhyay | Buy | $19.00 | High | View details for Guggenheim rating of Maze Therapeutics (NASDAQ:MAZE) on 2/25/2025 |
TEM Tempus AI | $46.17
-7.5% | 2/25/2025 | Reiterated by | Guggenheim | Analyst S. Nambi | Buy -> Buy | | Low | View details for Guggenheim rating of Tempus AI (NASDAQ:TEM) on 2/25/2025 |
VCYT Veracyte | $28.47
-5.5% | 2/25/2025 | Reiterated by | Guggenheim | Analyst S. Nambi | Buy -> Buy | $45.00 -> $45.00 | High | View details for Guggenheim rating of Veracyte (NASDAQ:VCYT) on 2/25/2025 |
CYBR CyberArk Software | $327.96
-5.1% | 2/25/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Buy -> Buy | $455.00 -> $455.00 | High | View details for Guggenheim rating of CyberArk Software (NASDAQ:CYBR) on 2/25/2025 |
TSLA Tesla | $267.28
-5.5% | 2/25/2025 | Reiterated by | Guggenheim | Analyst Ronald Jewsikow | Sell -> Sell | | High | View details for Guggenheim rating of Tesla (NASDAQ:TSLA) on 2/25/2025 |
INSM Insmed | $73.33
-0.1% | 2/25/2025 | Reiterated by | Guggenheim | Analyst Vamil Divan | Buy -> Buy | $101.00 -> $101.00 | Medium | View details for Guggenheim rating of Insmed (NASDAQ:INSM) on 2/25/2025 |
MTSR Metsera | $21.15
-6.7% | 2/25/2025 | Initiated by | Guggenheim | Analyst Seamus Fernandez | Buy | $56.00 | High | View details for Guggenheim rating of Metsera (NASDAQ:MTSR) on 2/25/2025 |
LNT Alliant Energy | $64.85
+0.6% | 2/24/2025 | Reiterated by | Guggenheim | Analyst Shahriar Pourreza | Neutral -> Neutral | $57.00 -> $57.00 | Medium | View details for Guggenheim rating of Alliant Energy (NASDAQ:LNT) on 2/24/2025 |
GH Guardant Health | $42.02
-3.4% | 2/24/2025 | Reiterated by | Guggenheim | Analyst Subbu Nambi | Buy -> Buy | $56.00 -> $56.00 | Medium | View details for Guggenheim rating of Guardant Health (NASDAQ:GH) on 2/24/2025 |
SPOT Spotify Technology | $558.48
-1.2% | 2/24/2025 | Reiterated by | Guggenheim | Analyst Michael Morris | Buy -> Buy | $675.00 -> $675.00 | Low | View details for Guggenheim rating of Spotify Technology (NYSE:SPOT) on 2/24/2025 |
MLYS Mineralys Therapeutics | $13.53
-3.4% | 2/24/2025 | Reiterated by | Guggenheim | Analyst Seamus Fernandez | Buy -> Buy | | Low | View details for Guggenheim rating of Mineralys Therapeutics (NASDAQ:MLYS) on 2/24/2025 |
WMT Walmart | $87.10
-3.0% | 2/24/2025 | Reiterated by | Guggenheim | Analyst Robert Drbul | Buy -> Buy | $100.00 -> $100.00 | Low | View details for Guggenheim rating of Walmart (NYSE:WMT) on 2/24/2025 |
BRKR Bruker | $37.66
-8.5% | 2/24/2025 | Reiterated by | Guggenheim | Analyst S. Nambi | Buy -> Buy | | Low | View details for Guggenheim rating of Bruker (NASDAQ:BRKR) on 2/24/2025 |
TARS Tarsus Pharmaceuticals | $49.55
-3.8% | 2/24/2025 | Reiterated by | Guggenheim | Analyst Eddie Hickman | Buy -> Buy | $75.00 -> $78.00 | High | View details for Guggenheim rating of Tarsus Pharmaceuticals (NASDAQ:TARS) on 2/24/2025 |
ARQT Arcutis Biotherapeutics | $16.16
-2.7% | 2/24/2025 | Reiterated by | Guggenheim | Analyst Seamus Fernandez | Buy -> Buy | | High | View details for Guggenheim rating of Arcutis Biotherapeutics (NASDAQ:ARQT) on 2/24/2025 |
EU’s Action Takes Aim At US Retirees (Ad) Trump's Return Sparks Massive Gold Rush—Is Your 401(k) Ready for the Fallout?
With President Trump back and global powers like China, Russia, and even Europe rapidly moving away from the U.S. dollar, central banks and financial giants are frantically buying gold at historic rates. This massive shift threatens your retirement savings with inflation and market instability—potentially worse than 2008. But you can protect yourself today by leveraging a little-known IRS loophole that lets you diversify your IRA or 401(k) into gold—tax-free and penalty-free. Claim Your FREE 2025 Gold Guide Now—And Shield Your Wealth Before Gold Prices Skyrocket Further! |
RIVN Rivian Automotive | $11.53
-7.7% | 2/24/2025 | Target Lowered by | Guggenheim | Analyst Ronald Jewsikow | Buy -> Buy | $18.00 -> $16.00 | Low | View details for Guggenheim rating of Rivian Automotive (NASDAQ:RIVN) on 2/24/2025 |
WING Wingstop | $242.78
+2.9% | 2/24/2025 | Upgraded by | Guggenheim | Analyst Gregory Francfort | Neutral -> Buy | $280.00 | Low | View details for Guggenheim rating of Wingstop (NASDAQ:WING) on 2/24/2025 |
CMPX Compass Therapeutics | $1.61
-5.0% | 2/24/2025 | Initiated by | Guggenheim | Analyst Michael Schmidt | Buy | $12.00 | Medium | View details for Guggenheim rating of Compass Therapeutics (NASDAQ:CMPX) on 2/24/2025 |
CHWY Chewy | $33.61
-1.2% | 2/4/2025 | Target Set by | Guggenheim | Analyst Steven Forbes | Buy -> Buy | $42.00 | Medium | View details for Guggenheim rating of Chewy (NYSE:CHWY) on 2/4/2025 |
ZVRA Zevra Therapeutics | $7.43
-3.0% | 2/4/2025 | Target Set by | Guggenheim | Analyst E. Hickman | Buy -> Buy | $21.00 | High | View details for Guggenheim rating of Zevra Therapeutics (NASDAQ:ZVRA) on 2/4/2025 |
VG Venture Global | $8.94
-10.2% | 2/18/2025 | Initiated by | Guggenheim | Analyst S. Pourreza | Buy | $27.00 | High | View details for Guggenheim rating of Venture Global (NYSE:VG) on 2/18/2025 |
PCG PG&E | $17.26
-1.0% | 2/18/2025 | Downgraded by | Guggenheim | Analyst S. Pourreza | Buy -> Neutral | | Low | View details for Guggenheim rating of PG&E (NYSE:PCG) on 2/18/2025 |
NKE NIKE | $55.49
-14.6% | 2/12/2025 | Reiterated by | Guggenheim | Analyst Robert Drbul | Buy -> Buy | $110.00 -> $110.00 | Low | View details for Guggenheim rating of NIKE (NYSE:NKE) on 2/12/2025 |
CPRI Capri | $15.06
-23.3% | 2/12/2025 | Reiterated by | Guggenheim | Analyst R. Drbul | Buy -> Buy | $30.00 -> $30.00 | Medium | View details for Guggenheim rating of Capri (NYSE:CPRI) on 2/12/2025 |
MRUS Merus | $41.73
-3.0% | 2/12/2025 | Reiterated by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | | Low | View details for Guggenheim rating of Merus (NASDAQ:MRUS) on 2/12/2025 |
UTL Unitil | $58.39
+0.3% | 2/12/2025 | Reiterated by | Guggenheim | Analyst Shahriar Pourreza | Neutral -> Neutral | $55.00 -> $55.00 | High | View details for Guggenheim rating of Unitil (NYSE:UTL) on 2/12/2025 |
AN AutoNation | $159.48
-4.8% | 2/12/2025 | Reiterated by | Guggenheim | Analyst Ronald Jewsikow | Buy -> Buy | | Low | View details for Guggenheim rating of AutoNation (NYSE:AN) on 2/12/2025 |
MRK Merck & Co., Inc. | $86.32
-0.3% | 2/12/2025 | Target Lowered by | Guggenheim | Analyst Vamil Divan | Buy -> Buy | $122.00 -> $115.00 | Low | View details for Guggenheim rating of Merck & Co., Inc. (NYSE:MRK) on 2/12/2025 |
TDC Teradata | $21.32
-7.0% | 2/12/2025 | Target Lowered by | Guggenheim | Analyst Howard Ma | Buy -> Buy | $42.00 -> $37.00 | High | View details for Guggenheim rating of Teradata (NYSE:TDC) on 2/12/2025 |
CFLT Confluent | $21.20
-12.1% | 2/12/2025 | Target Raised by | Guggenheim | Analyst Howard Ma | Buy -> Buy | $35.00 -> $38.00 | High | View details for Guggenheim rating of Confluent (NASDAQ:CFLT) on 2/12/2025 |
OS Onestream | $20.16
-10.3% | 2/12/2025 | Reiterated by | Guggenheim | Analyst J. Difucci | Buy -> Buy | $35.00 -> $35.00 | High | View details for Guggenheim rating of Onestream (NASDAQ:OS) on 2/12/2025 |
ARVN Arvinas | $6.90
-3.9% | 2/12/2025 | Reiterated by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | $57.00 -> $57.00 | High | View details for Guggenheim rating of Arvinas (NASDAQ:ARVN) on 2/12/2025 |
EXEL Exelixis | $36.68
-1.0% | 2/12/2025 | Reiterated by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | $42.00 -> $42.00 | High | View details for Guggenheim rating of Exelixis (NASDAQ:EXEL) on 2/12/2025 |
FLNC Fluence Energy | $4.32
-11.1% | 2/11/2025 | Downgraded by | Guggenheim | Analyst J. Osha | Buy -> Sell | $26.00 -> $6.00 | High | View details for Guggenheim rating of Fluence Energy (NASDAQ:FLNC) on 2/11/2025 |
SNAP Snap | $8.06
-9.3% | 2/11/2025 | Downgraded by | Guggenheim | Analyst M. Morris | Buy -> Neutral | | Medium | View details for Guggenheim rating of Snap (NYSE:SNAP) on 2/11/2025 |
RZLT Rezolute | $2.74
-9.3% | 2/10/2025 | Reiterated by | Guggenheim | Analyst D. Chattopadhyay | Buy -> Buy | | Low | View details for Guggenheim rating of Rezolute (NASDAQ:RZLT) on 2/10/2025 |
TARS Tarsus Pharmaceuticals | $49.55
-3.8% | 2/10/2025 | Reiterated by | Guggenheim | Analyst Eddie Hickman | Buy -> Buy | | Medium | View details for Guggenheim rating of Tarsus Pharmaceuticals (NASDAQ:TARS) on 2/10/2025 |
APGE Apogee Therapeutics | $34.99
-7.5% | 2/10/2025 | Reiterated by | Guggenheim | Analyst Seamus Fernandez | Buy -> Buy | | Low | View details for Guggenheim rating of Apogee Therapeutics (NASDAQ:APGE) on 2/10/2025 |
ARQT Arcutis Biotherapeutics | $16.16
-2.7% | 2/10/2025 | Reiterated by | Guggenheim | Analyst Seamus Fernandez | Buy -> Buy | | High | View details for Guggenheim rating of Arcutis Biotherapeutics (NASDAQ:ARQT) on 2/10/2025 |
ORIC ORIC Pharmaceuticals | $5.26
-9.0% | 2/10/2025 | Reiterated by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | | High | View details for Guggenheim rating of ORIC Pharmaceuticals (NASDAQ:ORIC) on 2/10/2025 |
ES Eversource Energy | $61.81
-1.3% | 2/10/2025 | Reiterated by | Guggenheim | Analyst Shahriar Pourreza | Buy -> Buy | | High | View details for Guggenheim rating of Eversource Energy (NYSE:ES) on 2/10/2025 |
CNTA Centessa Pharmaceuticals | $13.06
-4.7% | 2/10/2025 | Reiterated by | Guggenheim | Analyst Debjit Chattopadhyay | Buy -> Buy | | High | View details for Guggenheim rating of Centessa Pharmaceuticals (NASDAQ:CNTA) on 2/10/2025 |
IMVT Immunovant | $15.78
-3.9% | 2/10/2025 | Target Lowered by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | $46.00 -> $44.00 | High | View details for Guggenheim rating of Immunovant (NASDAQ:IMVT) on 2/10/2025 |
NBIX Neurocrine Biosciences | $102.88
-5.0% | 2/10/2025 | Target Lowered by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | $165.00 -> $163.00 | High | View details for Guggenheim rating of Neurocrine Biosciences (NASDAQ:NBIX) on 2/10/2025 |
PFE Pfizer | $24.30
-1.6% | 2/10/2025 | Reiterated by | Guggenheim | Analyst Vamil Divan | Buy -> Buy | $33.00 -> $33.00 | Low | View details for Guggenheim rating of Pfizer (NYSE:PFE) on 2/10/2025 |
RL Ralph Lauren | $197.84
-16.3% | 2/7/2025 | Target Raised by | Guggenheim | Analyst Robert Drbul | Buy -> Buy | $285.00 -> $310.00 | Low | View details for Guggenheim rating of Ralph Lauren (NYSE:RL) on 2/7/2025 |
INSM Insmed | $73.33
-0.1% | 2/7/2025 | Target Raised by | Guggenheim | Analyst Vamil Divan | Buy -> Buy | $95.00 -> $101.00 | Low | View details for Guggenheim rating of Insmed (NASDAQ:INSM) on 2/7/2025 |
KR Kroger | $70.59
+4.9% | 2/7/2025 | Target Raised by | Guggenheim | Analyst John Heinbockel | Buy -> Buy | $68.00 -> $71.00 | Low | View details for Guggenheim rating of Kroger (NYSE:KR) on 2/7/2025 |
TPR Tapestry | $65.11
-12.9% | 2/7/2025 | Target Raised by | Guggenheim | Analyst Robert Drbul | Buy -> Buy | $70.00 -> $90.00 | Low | View details for Guggenheim rating of Tapestry (NYSE:TPR) on 2/7/2025 |
FTNT Fortinet | $89.44
-8.8% | 2/7/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Neutral -> Neutral | | High | View details for Guggenheim rating of Fortinet (NASDAQ:FTNT) on 2/7/2025 |
LESL Leslie's | $0.60
-13.5% | 2/7/2025 | Reiterated by | Guggenheim | Analyst Steven Forbes | Neutral -> Neutral | | High | View details for Guggenheim rating of Leslie’s (NASDAQ:LESL) on 2/7/2025 |
WMG Warner Music Group | $30.93
-0.7% | 2/7/2025 | Reiterated by | Guggenheim | Analyst Michael Morris | Buy -> Buy | $40.00 -> $40.00 | Medium | View details for Guggenheim rating of Warner Music Group (NASDAQ:WMG) on 2/7/2025 |
UAA Under Armour | $5.36
-18.9% | 2/7/2025 | Reiterated by | Guggenheim | Analyst Robert Drbul | Neutral -> Neutral | | Medium | View details for Guggenheim rating of Under Armour (NYSE:UAA) on 2/7/2025 |
CMS CMS Energy | $75.46
+1.1% | 2/7/2025 | Reiterated by | Guggenheim | Analyst S. Pourreza | Neutral -> Neutral | $69.00 -> $69.00 | Medium | View details for Guggenheim rating of CMS Energy (NYSE:CMS) on 2/7/2025 |
ORLY O'Reilly Automotive | $1,441.89
+1.8% | 2/7/2025 | Target Raised by | Guggenheim | Analyst Steven Forbes | Buy -> Buy | $1,400.00 -> $1,475.00 | Medium | View details for Guggenheim rating of O’Reilly Automotive (NASDAQ:ORLY) on 2/7/2025 |
NET Cloudflare | $107.46
-10.1% | 2/7/2025 | Target Raised by | Guggenheim | Analyst John Difucci | Sell -> Sell | $57.00 -> $68.00 | High | View details for Guggenheim rating of Cloudflare (NYSE:NET) on 2/7/2025 |
PINS Pinterest | $27.54
-12.2% | 2/7/2025 | Target Raised by | Guggenheim | Analyst Michael Morris | Neutral -> Neutral | $33.00 -> $39.00 | High | View details for Guggenheim rating of Pinterest (NYSE:PINS) on 2/7/2025 |
ILMN Illumina | $76.42
-6.7% | 2/7/2025 | Target Lowered by | Guggenheim | Analyst Subbu Nambi | Buy -> Buy | $170.00 -> $150.00 | High | View details for Guggenheim rating of Illumina (NASDAQ:ILMN) on 2/7/2025 |
FOXA FOX | $51.83
-9.1% | 2/5/2025 | Target Raised by | Guggenheim | Analyst Michael Morris | Buy -> Buy | $55.00 -> $60.00 | Medium | View details for Guggenheim rating of FOX (NASDAQ:FOXA) on 2/5/2025 |
SPOT Spotify Technology | $558.48
-1.2% | 2/5/2025 | Target Raised by | Guggenheim | Analyst Michael Morris | Buy -> Buy | $520.00 -> $675.00 | Medium | View details for Guggenheim rating of Spotify Technology (NYSE:SPOT) on 2/5/2025 |
NJR New Jersey Resources | $49.73
+0.3% | 2/5/2025 | Target Raised by | Guggenheim | Analyst Shahriar Pourreza | Neutral -> Neutral | $53.00 -> $54.00 | Medium | View details for Guggenheim rating of New Jersey Resources (NYSE:NJR) on 2/5/2025 |
LEVI Levi Strauss & Co. | $14.43
-13.7% | 2/3/2025 | Target Raised by | Guggenheim | Analyst Robert Drbul | Buy -> Buy | $20.00 -> $22.00 | Low | View details for Guggenheim rating of Levi Strauss & Co. (NYSE:LEVI) on 2/3/2025 |
JNJ Johnson & Johnson | $159.90
+2.9% | 2/3/2025 | Target Raised by | Guggenheim | Analyst Vamil Divan | Neutral -> Neutral | $162.00 -> $166.00 | Low | View details for Guggenheim rating of Johnson & Johnson (NYSE:JNJ) on 2/3/2025 |
ABBV AbbVie | $201.31
-1.9% | 2/3/2025 | Target Raised by | Guggenheim | Analyst Vamil Divan | Buy -> Buy | $212.00 -> $214.00 | High | View details for Guggenheim rating of AbbVie (NYSE:ABBV) on 2/3/2025 |
CROX Crocs | $95.97
-14.0% | 2/3/2025 | Target Lowered by | Guggenheim | Analyst R. Drbul | Buy -> Buy | $155.00 -> $150.00 | High | View details for Guggenheim rating of Crocs (NASDAQ:CROX) on 2/3/2025 |
EU’s Action Takes Aim At US Retirees (Ad) Trump's Return Sparks Massive Gold Rush—Is Your 401(k) Ready for the Fallout?
With President Trump back and global powers like China, Russia, and even Europe rapidly moving away from the U.S. dollar, central banks and financial giants are frantically buying gold at historic rates. This massive shift threatens your retirement savings with inflation and market instability—potentially worse than 2008. But you can protect yourself today by leveraging a little-known IRS loophole that lets you diversify your IRA or 401(k) into gold—tax-free and penalty-free. Claim Your FREE 2025 Gold Guide Now—And Shield Your Wealth Before Gold Prices Skyrocket Further! |
CFLT Confluent | $21.20
-12.1% | 1/31/2025 | Target Raised by | Guggenheim | Analyst Howard Ma | Buy -> Buy | $32.00 -> $35.00 | Medium | View details for Guggenheim rating of Confluent (NASDAQ:CFLT) on 1/31/2025 |
INFA Informatica | $16.99
-4.3% | 1/31/2025 | Reiterated by | Guggenheim | Analyst Howard Ma | Buy -> Buy | $37.00 -> $37.00 | Medium | View details for Guggenheim rating of Informatica (NYSE:INFA) on 1/31/2025 |
DECK Deckers Outdoor | $100.95
-14.4% | 1/31/2025 | Reiterated by | Guggenheim | Analyst R. Drbul | Neutral -> Neutral | | High | View details for Guggenheim rating of Deckers Outdoor (NYSE:DECK) on 1/31/2025 |
TSCO Tractor Supply | $55.77
+0.3% | 1/31/2025 | Reiterated by | Guggenheim | Analyst Steven Forbes | Buy -> Buy | $60.00 -> $60.00 | Medium | View details for Guggenheim rating of Tractor Supply (NASDAQ:TSCO) on 1/31/2025 |
CHKP Check Point Software Technologies | $224.02
-1.7% | 1/31/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Neutral -> Neutral | | Low | View details for Guggenheim rating of Check Point Software Technologies (NASDAQ:CHKP) on 1/31/2025 |
DT Dynatrace | $45.67
-5.6% | 1/31/2025 | Reiterated by | Guggenheim | Analyst J. Difucci | Neutral -> Neutral | | Low | View details for Guggenheim rating of Dynatrace (NYSE:DT) on 1/31/2025 |
ENPH Enphase Energy | $58.77
-6.0% | 1/31/2025 | Upgraded by | Guggenheim | Analyst J. Osha | Sell -> Neutral | $62.00 -> $62.00 | Medium | View details for Guggenheim rating of Enphase Energy (NASDAQ:ENPH) on 1/31/2025 |
TSLA Tesla | $267.28
-5.5% | 1/29/2025 | Reiterated by | Guggenheim | Analyst Ronald Jewsikow | Sell -> Sell | $175.00 -> $175.00 | Low | View details for Guggenheim rating of Tesla (NASDAQ:TSLA) on 1/29/2025 |
NXT Nextracker | $40.40
-7.2% | 1/29/2025 | Target Raised by | Guggenheim | Analyst Joseph Osha | Buy -> Buy | $50.00 -> $62.00 | Low | View details for Guggenheim rating of Nextracker (NASDAQ:NXT) on 1/29/2025 |
SIRI Sirius XM | $21.13
-5.4% | 1/29/2025 | Target Lowered by | Guggenheim | Analyst C. Baker | Buy -> Buy | $30.00 -> $29.00 | Medium | View details for Guggenheim rating of Sirius XM (NASDAQ:SIRI) on 1/29/2025 |
RL Ralph Lauren | $197.84
-16.3% | 1/29/2025 | Target Raised by | Guggenheim | Analyst Robert Drbul | Buy -> Buy | $260.00 -> $285.00 | Low | View details for Guggenheim rating of Ralph Lauren (NYSE:RL) on 1/29/2025 |
XIFR XPLR Infrastructure | $9.25
-0.5% | 1/29/2025 | Target Lowered by | Guggenheim | Analyst S. Pourreza | Neutral -> Neutral | $17.00 -> $12.00 | Low | View details for Guggenheim rating of XPLR Infrastructure (NYSE:XIFR) on 1/29/2025 |
SYY Sysco | $75.27
0.0% | 1/29/2025 | Reiterated by | Guggenheim | Analyst John Heinbockel | Buy -> Buy | $85.00 -> $85.00 | Low | View details for Guggenheim rating of Sysco (NYSE:SYY) on 1/29/2025 |
CVLT Commvault Systems | $152.89
-8.1% | 1/29/2025 | Reiterated by | Guggenheim | Analyst H. Ma | Neutral -> Neutral | | Low | View details for Guggenheim rating of Commvault Systems (NASDAQ:CVLT) on 1/29/2025 |
ELDN Eledon Pharmaceuticals | $3.16
-4.5% | 1/28/2025 | Initiated by | Guggenheim | Analyst V. Divan | Buy | $9.00 | High | View details for Guggenheim rating of Eledon Pharmaceuticals (NASDAQ:ELDN) on 1/28/2025 |
QSR Restaurant Brands International | C$95.50
-0.4% | 1/24/2025 | Upgraded by | Guggenheim | Analyst G. Francfort | Hold -> Strong-Buy | | N/A | View details for Guggenheim rating of Restaurant Brands International (TSE:QSR) on 1/24/2025 |
LEVI Levi Strauss & Co. | $14.43
-13.7% | 1/24/2025 | Reiterated by | Guggenheim | Analyst Robert Drbul | Buy -> Buy | $23.00 -> $23.00 | Low | View details for Guggenheim rating of Levi Strauss & Co. (NYSE:LEVI) on 1/24/2025 |
VSTM Verastem | $5.70
-2.4% | 1/24/2025 | Reiterated by | Guggenheim | Analyst M. Schmidt | Buy -> Buy | | High | View details for Guggenheim rating of Verastem (NASDAQ:VSTM) on 1/24/2025 |
VIGL Vigil Neuroscience | $1.67
-5.6% | 1/24/2025 | Reiterated by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | | High | View details for Guggenheim rating of Vigil Neuroscience (NASDAQ:VIGL) on 1/24/2025 |
UNP Union Pacific | $223.75
-6.2% | 1/24/2025 | Target Raised by | Guggenheim | Analyst Nathan Martin | Buy -> Buy | $266.00 -> $275.00 | Low | View details for Guggenheim rating of Union Pacific (NYSE:UNP) on 1/24/2025 |
TGNA TEGNA | $17.12
-9.8% | 1/24/2025 | Reiterated by | Guggenheim | Analyst Curry Baker | Buy -> Buy | $22.00 -> $22.00 | Low | View details for Guggenheim rating of TEGNA (NYSE:TGNA) on 1/24/2025 |
MSFT Microsoft | $373.11
-2.4% | 1/24/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Neutral -> Neutral | | Low | View details for Guggenheim rating of Microsoft (NASDAQ:MSFT) on 1/24/2025 |
DYN Dyne Therapeutics | $9.42
-4.9% | 1/24/2025 | Reiterated by | Guggenheim | Analyst Debjit Chattopadhyay | Buy -> Buy | | Medium | View details for Guggenheim rating of Dyne Therapeutics (NASDAQ:DYN) on 1/24/2025 |
FTNT Fortinet | $89.44
-8.8% | 1/24/2025 | Reiterated by | Guggenheim | Analyst R. Mcdonough | Neutral -> Neutral | | Low | View details for Guggenheim rating of Fortinet (NASDAQ:FTNT) on 1/24/2025 |
CHKP Check Point Software Technologies | $224.02
-1.7% | 1/24/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Neutral -> Neutral | | Low | View details for Guggenheim rating of Check Point Software Technologies (NASDAQ:CHKP) on 1/24/2025 |
ORLY O'Reilly Automotive | $1,441.89
+1.8% | 1/24/2025 | Target Raised by | Guggenheim | Analyst Steven Forbes | Buy -> Buy | $1,275.00 -> $1,400.00 | Low | View details for Guggenheim rating of O’Reilly Automotive (NASDAQ:ORLY) on 1/24/2025 |
QSR Restaurant Brands International | $67.76
+1.3% | 1/24/2025 | Upgraded by | Guggenheim | Analyst Gregory Francfort | Neutral -> Buy | $74.00 -> $71.00 | Low | View details for Guggenheim rating of Restaurant Brands International (NYSE:QSR) on 1/24/2025 |
GEV GE Vernova | $297.33
-10.1% | 1/24/2025 | Downgraded by | Guggenheim | Analyst J. Osha | Buy -> Neutral | $380.00 -> $380.00 | High | View details for Guggenheim rating of GE Vernova (NYSE:GEV) on 1/24/2025 |
SO Southern | $92.44
+1.2% | 1/23/2025 | Downgraded by | Guggenheim | Analyst S. Pourreza | Buy -> Neutral | | Low | View details for Guggenheim rating of Southern (NYSE:SO) on 1/23/2025 |
EIX Edison International | $58.30
-2.7% | 1/23/2025 | Downgraded by | Guggenheim | Analyst S. Pourreza | Buy -> Neutral | | Medium | View details for Guggenheim rating of Edison International (NYSE:EIX) on 1/23/2025 |
CMS CMS Energy | $75.46
+1.1% | 1/23/2025 | Downgraded by | Guggenheim | Analyst S. Pourreza | Buy -> Neutral | | Medium | View details for Guggenheim rating of CMS Energy (NYSE:CMS) on 1/23/2025 |
CNP CenterPoint Energy | $37.36
+1.2% | 1/23/2025 | Downgraded by | Guggenheim | Analyst S. Pourreza | Buy -> Neutral | | Low | View details for Guggenheim rating of CenterPoint Energy (NYSE:CNP) on 1/23/2025 |
NWE NorthWestern Energy Group | $58.10
-1.4% | 1/23/2025 | Upgraded by | Guggenheim | Analyst S. Pourreza | Neutral -> Buy | | Medium | View details for Guggenheim rating of NorthWestern Energy Group (NYSE:NWE) on 1/23/2025 |
IDA IDACORP | $119.83
+0.6% | 1/23/2025 | Upgraded by | Guggenheim | Analyst S. Pourreza | Neutral -> Buy | | Medium | View details for Guggenheim rating of IDACORP (NYSE:IDA) on 1/23/2025 |
EXC Exelon | $47.23
+2.7% | 1/23/2025 | Upgraded by | Guggenheim | Analyst S. Pourreza | Neutral -> Buy | | Low | View details for Guggenheim rating of Exelon (NASDAQ:EXC) on 1/23/2025 |
EVRG Evergy | $69.21
-0.3% | 1/23/2025 | Upgraded by | Guggenheim | Analyst S. Pourreza | Neutral -> Buy | | Low | View details for Guggenheim rating of Evergy (NASDAQ:EVRG) on 1/23/2025 |
DTE DTE Energy | $139.36
+1.0% | 1/23/2025 | Upgraded by | Guggenheim | Analyst S. Pourreza | Neutral -> Buy | | High | View details for Guggenheim rating of DTE Energy (NYSE:DTE) on 1/23/2025 |
AEP American Electric Power | $109.11
+1.3% | 1/23/2025 | Upgraded by | Guggenheim | Analyst S. Pourreza | Neutral -> Buy | | Medium | View details for Guggenheim rating of American Electric Power (NASDAQ:AEP) on 1/23/2025 |
NXST Nexstar Media Group | $166.96
-8.2% | 1/22/2025 | Reiterated by | Guggenheim | Analyst Curry Baker | Buy -> Buy | | Low | View details for Guggenheim rating of Nexstar Media Group (NASDAQ:NXST) on 1/22/2025 |
GH Guardant Health | $42.02
-3.4% | 1/22/2025 | Reiterated by | Guggenheim | Analyst Subbu Nambi | Buy -> Buy | | High | View details for Guggenheim rating of Guardant Health (NASDAQ:GH) on 1/22/2025 |
FSLR First Solar | $136.23
+4.9% | 1/22/2025 | Reiterated by | Guggenheim | Analyst Joseph Osha | Buy -> Buy | $335.00 -> $335.00 | High | View details for Guggenheim rating of First Solar (NASDAQ:FSLR) on 1/22/2025 |
DT Dynatrace | $45.67
-5.6% | 1/22/2025 | Reiterated by | Guggenheim | Analyst J. Difucci | Neutral -> Neutral | | Low | View details for Guggenheim rating of Dynatrace (NYSE:DT) on 1/22/2025 |
EXEL Exelixis | $36.68
-1.0% | 1/22/2025 | Reiterated by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | | High | View details for Guggenheim rating of Exelixis (NASDAQ:EXEL) on 1/22/2025 |
IPSC Century Therapeutics | $0.46
-2.3% | 1/22/2025 | Reiterated by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | | Low | View details for Guggenheim rating of Century Therapeutics (NASDAQ:IPSC) on 1/22/2025 |
DDOG Datadog | $94.47
-7.1% | 1/22/2025 | Reiterated by | Guggenheim | Analyst Howard Ma | Neutral -> Neutral | | Low | View details for Guggenheim rating of Datadog (NASDAQ:DDOG) on 1/22/2025 |
NOW ServiceNow | $773.53
-6.1% | 1/22/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Sell -> Sell | $716.00 | Low | View details for Guggenheim rating of ServiceNow (NYSE:NOW) on 1/22/2025 |
NWSA News | $26.07
-3.7% | 1/22/2025 | Target Raised by | Guggenheim | Analyst Curry Baker | Buy -> Buy | $40.00 -> $43.00 | Low | View details for Guggenheim rating of News (NASDAQ:NWSA) on 1/22/2025 |
TGT Target | $94.24
-10.9% | 1/22/2025 | Target Raised by | Guggenheim | Analyst Robert Drbul | Buy -> Buy | $145.00 -> $155.00 | Low | View details for Guggenheim rating of Target (NYSE:TGT) on 1/22/2025 |
NFLX Netflix | $917.05
-2.0% | 1/22/2025 | Target Raised by | Guggenheim | Analyst Michael Morris | Buy -> Buy | $950.00 -> $1,100.00 | High | View details for Guggenheim rating of Netflix (NASDAQ:NFLX) on 1/22/2025 |
PRGS Progress Software | $57.99
-1.7% | 1/17/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Buy -> Buy | $83.00 -> $83.00 | High | View details for Guggenheim rating of Progress Software (NASDAQ:PRGS) on 1/17/2025 |
BRKR Bruker | $37.66
-8.5% | 1/17/2025 | Reiterated by | Guggenheim | Analyst S. Nambi | Buy -> Buy | | Medium | View details for Guggenheim rating of Bruker (NASDAQ:BRKR) on 1/17/2025 |
KROS Keros Therapeutics | $10.28
+2.4% | 1/17/2025 | Reiterated by | Guggenheim | Analyst V. Divan | Neutral -> Neutral | | Medium | View details for Guggenheim rating of Keros Therapeutics (NASDAQ:KROS) on 1/17/2025 |
NTRA Natera | $138.71
-3.1% | 1/17/2025 | Target Raised by | Guggenheim | Analyst Subbu Nambi | Buy -> Buy | $170.00 -> $200.00 | High | View details for Guggenheim rating of Natera (NASDAQ:NTRA) on 1/17/2025 |
INFY Infosys | $17.34
-5.7% | 1/17/2025 | Reiterated by | Guggenheim | Analyst Jonathan Lee | Neutral -> Neutral | | Low | View details for Guggenheim rating of Infosys (NYSE:INFY) on 1/17/2025 |
LTH Life Time Group | $29.33
-6.3% | 1/17/2025 | Reiterated by | Guggenheim | Analyst John Heinbockel | Buy -> Buy | $29.00 -> $32.00 | High | View details for Guggenheim rating of Life Time Group (NYSE:LTH) on 1/17/2025 |
OTLK Outlook Therapeutics | $1.21
-3.2% | 1/17/2025 | Reiterated by | Guggenheim | Analyst Eddie Hickman | Buy -> Buy | $12.00 -> $12.00 | High | View details for Guggenheim rating of Outlook Therapeutics (NASDAQ:OTLK) on 1/17/2025 |
NFLX Netflix | $917.05
-2.0% | 1/13/2025 | Target Raised by | Guggenheim | Analyst Michael Morris | Buy -> Buy | $825.00 -> $950.00 | Low | View details for Guggenheim rating of Netflix (NASDAQ:NFLX) on 1/13/2025 |
IGMS IGM Biosciences | $1.16
-5.7% | 1/10/2025 | Downgraded by | Guggenheim | Analyst M. Schmidt | Buy -> Neutral | | High | View details for Guggenheim rating of IGM Biosciences (NASDAQ:IGMS) on 1/10/2025 |
SWTX SpringWorks Therapeutics | $43.07
-7.4% | 1/8/2025 | Target Lowered by | Guggenheim | - | Buy -> Buy | $80.00 -> $78.00 | Medium | View details for Guggenheim rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 1/8/2025 |
WMG Warner Music Group | $30.93
-0.7% | 1/8/2025 | Target Lowered by | Guggenheim | - | Buy -> Buy | $44.00 -> $40.00 | Medium | View details for Guggenheim rating of Warner Music Group (NASDAQ:WMG) on 1/8/2025 |
